Sign In
Buy AGEN
$3.07
+0.0300 (+0.99%)
At Close: Jun 23, 2026
Hot Biotech Stocks That Deserve Your Attention In August 2021
11:56am, Wednesday, 11'th Aug 2021
Is it time to add biotech stocks to your list this year? The post Hot Biotech Stocks That Deserve Your Attention In August 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
Agenus' (AGEN) CEO Garo Armen on Q2 2021 Results - Earnings Call Transcript
02:38pm, Monday, 09'th Aug 2021
Agenus' (AGEN) CEO Garo Armen on Q2 2021 Results - Earnings Call Transcript
Agenus (AGEN) Reports Q2 Loss, Misses Revenue Estimates
10:50am, Monday, 09'th Aug 2021
Agenus (AGEN) delivered earnings and revenue surprises of -54.17% and -36.75%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Agenus Q2 Earnings
08:05am, Monday, 09'th Aug 2021
Shares of Agenus (NASDAQ:AGEN) moved higher by 2.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 32.14% over the past year to ($0.37), wh
Agenus Corporate Update and Second Quarter 2021 Financial Report
07:45am, Monday, 09'th Aug 2021
LEXINGTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines
Will Agenus (AGEN) Report Negative Earnings Next Week? What You Should Know
04:46pm, Monday, 02'nd Aug 2021
Agenus (AGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MiNK Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
08:30am, Wednesday, 28'th Jul 2021
NEW YORK, July 28, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commissio
Why Agenus Stock Sank on Tuesday
06:21pm, Tuesday, 27'th Jul 2021
A top company executive is stepping down in the very near future.
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
04:05pm, Wednesday, 07'th Jul 2021
LEXINGTON, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines desig
Moving Average Crossover Alert: Agenus (AGEN)
07:31am, Tuesday, 06'th Jul 2021
Agenus (AGEN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Agenus (AGEN) Is a Great Choice for "Trend" Investors, Here's Why
09:46am, Monday, 05'th Jul 2021
Agenus (AGEN) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our sho
AGEN Stock Price Increased 6.4%: Why It Happened
05:14am, Friday, 18'th Jun 2021
The stock price of Agenus Inc. (Nasdaq: AGEN) increased by 6.4% yesterday. This is why it happened.
Why Agenus Stock Is Marching Higher Today
01:01pm, Thursday, 17'th Jun 2021
The biotech took a major step toward becoming a commercial-stage cancer company.
Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer
10:23am, Thursday, 17'th Jun 2021
The FDA has accepted for review Agenus Inc's (NASDAQ: AGEN) marketing application seeking approval for balstilimab for recurrent or metastatic cervical cancer with disease progression on or after c
LEXINGTON, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents which includes checkpoint antibodies, cell therapies, ad
